Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Loading...
Community
/
United States
/
Software
/
Enfusion
Create a narrative
Enfusion Community
NYSE:ENFN Community
1
Narratives
written by author
0
Comments
on narratives written by author
12
Fair Values set
on narratives written by author
Community Investing Ideas
Enfusion
Popular
Undervalued
Overvalued
Enfusion
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Geographic Expansion And New Products Will Strengthen Market Position
Key Takeaways Expansion into EMEA and the Middle East is key to improving market share and client momentum. New product features and geographic growth will drive increased revenue and profitability.
View narrative
US$15.25
FV
4.4% undervalued
intrinsic discount
15.72%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
5 months ago
author updated this narrative
Your Valuation for
ENFN
ENFN
Enfusion
Your Fair Value
US$
Current Price
US$10.76
15.7% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-188m
399m
2015
2018
2021
2024
2025
2027
2030
Revenue US$399.5m
Earnings US$5.6m
Advanced
Set Fair Value